2023-07-26

The ZSHK COO Jin Yi was requested to speak at the 2023 Shenzhen International Biomedical Industry Innovation and Development Conference

From July 27th to 29th, 2023, Anling Biomed (Shenzhen) Co., Ltd. (hereinafter referred to as Anling Shenzhen), a wholly owned subsidiary of ZSHK Laboratories Limited. (hereinafter referred to as ZSHK), was invited to participate in the 2023 ...

Read more +

2023-07-17

Highlights Review | Summary of ZSHK's Activities in the First Half of 2023:

From February 27th to March 3rd, ZSHK accompanied a delegation from the China Pharmaceutical Innovation and Research Development Association (PhIRDA) on a visit to Hong Kong and Singapore. They also held a reception dinner in Hong Kong, wher...

Read more +

2023-06-08

Activity review The Inauguration Ceremony of Anling Biomed (Shenzhen) GLP Center was Successfully Held

On the afternoon of June 8, 2023, the Anling Biomed (Shenzhen) GLP Center officially commenced its operation. Anling Biomed, carrying the love and expectations of its customers, set sail to fulfill the expectations by providing quality servi...

Read more +

2023-06-01

Empowering Original Innovation | Key Factors in Early Drug-like Properties Evaluation of Chemical Compounds -ZSHK & MacauU

With the strengthening of Chinas economic and technological capabilities, the research and development of new drugs will inevitably aim for higher goals, achieving a new historical transformation. This transition will progress from imitative...

Read more +

2023-05-19

ZSHK attended the 3rd Asia Medical and Health Summit

May 17, 2023, Hong Kong, China. The 3rd Asia Medical and Health Summit (ASGH), jointly organized by the Hong Kong Special Administrative Region Government and the Hong Kong Trade Development Council, was grandly held at the Hong Kong Convent...

Read more +